KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,809,000 | +56.4% | 27,100 | +18.5% | 0.20% | +55.9% |
| Q1 2017 | $1,796,000 | -42.7% | 22,871 | -59.2% | 0.13% | -38.9% |
| Q3 2016 | $3,132,000 | +69.8% | 56,066 | +52.0% | 0.21% | +62.5% |
| Q2 2016 | $1,845,000 | +37.7% | 36,897 | +26.4% | 0.13% | +30.6% |
| Q1 2016 | $1,340,000 | -29.1% | 29,181 | -14.0% | 0.10% | -27.4% |
| Q3 2015 | $1,889,000 | -1.2% | 33,919 | +8.2% | 0.14% | +10.7% |
| Q2 2015 | $1,912,000 | – | 31,354 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |